Diabetes drug market set for $163.79b as type 2 cases climb
The global diabetes drug market is projected to reach $163.79 billion by 2034, driven by rising type 2 diabetes cases and an aging population. Growth is supported by new drug classes like GLP-1 receptor agonists and SGLT-2 inhibitors, with North America leading the market.
Why it matters
This growth highlights the increasing economic and public health burden of chronic metabolic diseases and the shift toward specialized pharmaceutical interventions.
Published: 14 minutes ago Photo by isens usa via Unsplash Diabetes drug market set for $163.79b as type 2 cases climb This is fuelled by ageing population and sedentary lifestyles.
The global diabetes drug market is projected to hit $163.79b by 2034, driven by rising global diabetes rates, particularly type 2 , fuelled by ageing populations, sedentary lifestyles, and increasing obesity, according to Polaris Market Research.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in